Open Access

[Corrigendum] miR‑199b‑5p serves as a tumor suppressor in renal cell carcinoma

  • Authors:
    • Yulin Lai
    • Jing Quan
    • Canbin Lin
    • Hang Li
    • Jia Hu
    • Peijie Chen
    • Jinling Xu
    • Xin Guan
    • Weijie Xu
    • Yongqing Lai
    • Liangchao Ni
  • View Affiliations

  • Published online on: February 9, 2024     https://doi.org/10.3892/etm.2024.12422
  • Article Number: 134
  • Copyright : © Lai et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Exp Ther Med 16:[Related article:] 436–444, 2018; DOI: 10.3892/etm.2018.6151

Following the publication of the above article and a corrigendum (10.3892/etm.2018.6333) that was concerned with changes in the authorship and affiliation details on the paper, an interested reader has drawn to the authors’ attention that, in Fig. 5A on p. 441, the ‘ACHN/cell invasion/miR-199b-5p inhibitor’ and ‘ACHN/cell invasion/NCin’ data panels appeared to show an overlapping section of data, such that they were derived from the same original source when they were intended to show the results from differently performed experiments.

The authors have re-examined their data, and realize that the ‘ACHN/cell invasion/NCin’ data panel was inadvertently selected incorrectly. The corrected version of Fig. 5, now containing the correct data for the ‘ACHN/cell invasion/NCin’ experiment, is shown on the next page. Note that the error made during the compilation of this figure did not affect the overall conclusions reported in the paper. All the authors agree with the publication of this corrigendum, and are grateful to the Editor of Experimental and Therapeutic Medicine for offering them the opportunity to publish this. They also apologize to the readership for any inconvenience caused.

Related Articles

Journal Cover

April-2024
Volume 27 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Lai Y, Quan J, Lin C, Li H, Hu J, Chen P, Xu J, Guan X, Xu W, Lai Y, Lai Y, et al: [Corrigendum] miR‑199b‑5p serves as a tumor suppressor in renal cell carcinoma. Exp Ther Med 27: 134, 2024.
APA
Lai, Y., Quan, J., Lin, C., Li, H., Hu, J., Chen, P. ... Ni, L. (2024). [Corrigendum] miR‑199b‑5p serves as a tumor suppressor in renal cell carcinoma. Experimental and Therapeutic Medicine, 27, 134. https://doi.org/10.3892/etm.2024.12422
MLA
Lai, Y., Quan, J., Lin, C., Li, H., Hu, J., Chen, P., Xu, J., Guan, X., Xu, W., Lai, Y., Ni, L."[Corrigendum] miR‑199b‑5p serves as a tumor suppressor in renal cell carcinoma". Experimental and Therapeutic Medicine 27.4 (2024): 134.
Chicago
Lai, Y., Quan, J., Lin, C., Li, H., Hu, J., Chen, P., Xu, J., Guan, X., Xu, W., Lai, Y., Ni, L."[Corrigendum] miR‑199b‑5p serves as a tumor suppressor in renal cell carcinoma". Experimental and Therapeutic Medicine 27, no. 4 (2024): 134. https://doi.org/10.3892/etm.2024.12422